Skip to content

13F-HR filed by Lion Point Capital, LP

Lion Point Capital, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 20:49:17 UTC, with 34 holding rows worth $17,261,149.

Accession
0001013594-26-001194
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 34 entries on the cover page, a total value of $17,261,149 stated on the cover page (in dollars after the unit check, H1), rows summing to $17,261,149 with VALUE read as dollars as filed, 13F file number 028-17316. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CUE BIOPHARMA INC22978P205COM52,928$1,369,247dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW4,450$1,295,974dollars as filed
ROYALTY PHARMA PLCG7709Q104SHS CLASS A21,400$1,248,904dollars as filed
FENNEC PHARMACEUTICALS INC31447P100COMMON STOCK112,434$1,197,422dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS80,000$995,200dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock67,500$789,750dollars as filed
GERON CORP374163103COM578,000$710,940dollars as filed
Milestone Pharmaceuticals Inc59935V107COM820,000$709,874dollars as filed
BIOHAVEN LTDG1110E107COM51,700$690,195dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM36,000$676,800dollars as filed
BENITEC BIOPHARMA INC08205P209COMMON STOCK62,000$620,000dollars as filed
DISC MEDICINE INC COM254604101Stock8,100$530,226dollars as filed
SAREPTA THERAPEUTICS INC803607100COM28,500$519,270dollars as filed
KURA ONCOLOGY INC COM50127T109Stock46,000$492,660dollars as filed
VIATRIS INC COM92556V106Stock27,700$490,844dollars as filed
ARDELYX INC039697107COM128,650$439,983dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM9,100$369,460dollars as filed
UNIQURE NVN90064101SHS14,700$355,152dollars as filed
AZENTA INC114340102COM9,700$338,433dollars as filed
PACIRA BIOSCIENCES INC COM695127100Stock13,500$338,175dollars as filed
HUMACYTE INC44486Q103COM650,000$336,505dollars as filed
BRIDGEBIO PHARMA INC10806X102COM5,000$329,000dollars as filed
JANUX THERAPEUTICS INC47103J105COM19,000$328,320dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock18,000$289,980dollars as filed
JASPER THERAPEUTICS INC471871202COM NEW465,000$269,700dollars as filed
MINERALYS THERAPEUTICS INC603170101COM10,500$263,865dollars as filed
GH RESEARCH PLC ORDINARY SHARESG3855L106Stock10,200$239,496dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM86,000$226,180dollars as filed
REGENXBIO INC75901B107COM26,600$200,298dollars as filed
INNOVIVA INC45781M101COM8,200$173,922dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM5,250$138,758dollars as filed
INNATE PHARMA S A45781K204SPONSORED ADS81,151$132,276dollars as filed
SERES THERAPEUTICS INC81750R201CMN31,570$105,760dollars as filed
SPRUCE BIOSCIENCES INC85209E208COM NEW1,000$48,580dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001013594-26-001194this filing2026-11-16